Cannabix Technologies Inc. (CSE:BLO) (OTC:BLOZF) has released images of its new prototype, Beta 2.0 Cannabix marijuana breathalyzer. Images of the device can be found here. Development of the company’s marijuana breathalyzer has moved to the next stage to the Beta 2.0 prototype.
The Cannabix Marijuana Breathalyzer Beta 2.0 has been compacted to a black box that has reduced in size. It packs latest chip technology with improved reaction time and performance. The Beta 2.0 exploits FAIMSdetection technology which is the most sensitive and scientifically proven method of detection of volatile compounds found in exhaled breath.
The Beta 2.0 prototype will be used to conduct tests on live marijuana users (smokers and edible consumers) to test for accuracy. Results of the tests will be used to propose for approval of the Breathalyzer through the Minister of Justice in Canada and the National Highway Traffic Safety Administration (NHTSA) in the United States. Law enforcement officials and regulators will be consulted regarding the ease of use and efficiency of the breathalyzer. The testing protocol will be designed by Cannabix’s Dr. Raj Attariwala with aid from the Company’s scientific advisors.
Head of Analytical Chemistry at the university of Florida and Scientific Advisor on Cannabix Marijuana breathalyzer states, “When Cannabix first approached our lab with the goal of building a device that could detect trace amounts of THC through exhaled breath, we were excited to face the challenge. We have been able to use our expertise and patent in FAIMS technology and build a device that achieves the required sensitivity and specificity but also will be a handheld portable device, similar to alcohol breathalyzers. We are extremely pleased and proud to be working on the design of a portable Cannabix Marijuana Breathalyzer that will be used by Law Enforcement to collect evidence of impaired driving and ensure safety on our roads as marijuana use becomes accepted in society and its use continues to grow.”